Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
FREZENT Logo
FREZENT Growth Score
7
CB Rank
303929
Heat Score
61
FREZENT is a biotechnology company that develops novel therapeutics for advanced-stage cancer patients.
Founded
obfuscation
PrivateSeed New York, New York, United States1-10 www.frezent.com/
Biotechnology
Health Care
Medical
Therapeutics
Overview

FREZENT
Growth Score
7
Heat Score
61

Growth Score7
-7 pts
in past quarter
Heat Score 61
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About FREZENT

CB Rank
303929
FREZENT is a biotechnology company that develops novel therapeutics for advanced-stage cancer patients.
Founded
obfuscation
PrivateSeed New York, New York, United States1-10 www.frezent.com/
Biotechnology
Health Care
Medical
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name FREZENT Biological Solutions Inc
Operating Status Active
Company Type For Profit
Founders  Natasha Shtraizent
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

Bifunctional Therapeutic Modalities
Therapeutic agents designed to target non-dividing, dormant cancer cells by blocking essential metabolic programs, preventing their transformation into recurrent cancer.
Bispecific Antibodies
Antibodies engineered to bind to two different antigens, used to target and neutralize dormant cancer cells.

Research & Development

FREZENT is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - FREZENT Logo
Seed Round - FREZENT
2
obfuscation
— Seed
obfuscation
Seed Round - FREZENT Logo
Seed Round - FREZENT
2
obfuscation
— Seed
obfuscation
Seed Round - FREZENT Logo
Seed Round - FREZENT
2
obfuscation
— Seed
obfuscation
Seed Round - FREZENT Logo
Seed Round - FREZENT
2
obfuscation
— Seed
obfuscation
Seed Round - FREZENT Logo
Seed Round - FREZENT
2
obfuscation
— Seed

Funding Rounds

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - FREZENT Logo
Seed Round - FREZENT
2
obfuscation
— Seed
obfuscation
Seed Round - FREZENT Logo
Seed Round - FREZENT
2
obfuscation
— Seed
obfuscation
Seed Round - FREZENT Logo
Seed Round - FREZENT
2
obfuscation
— Seed
obfuscation
Seed Round - FREZENT Logo
Seed Round - FREZENT
2
obfuscation
— Seed
obfuscation
Seed Round - FREZENT Logo
Seed Round - FREZENT
2
obfuscation
— Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
SOSV Logo
SOSV
—
Seed Round - FREZENT Logo
Seed Round - FREZENT
Stephen Chambers
SOSV Logo
SOSV
—
Seed Round - FREZENT Logo
Seed Round - FREZENT
Stephen Chambers
SOSV Logo
SOSV
—
Seed Round - FREZENT Logo
Seed Round - FREZENT
Stephen Chambers
SOSV Logo
SOSV
—
Seed Round - FREZENT Logo
Seed Round - FREZENT
Stephen Chambers
SOSV Logo
SOSV
—
Seed Round - FREZENT Logo
Seed Round - FREZENT
Stephen Chambers
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Board Members and Advisors 1 Contacts 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Apr 5, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$492.9KThis year, FREZENT is projected to spend $492.9K on IT, according to Aberdeen.

Active Website Tech Count

2FREZENT is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 10m.

Total IP

2The intellectual property of FREZENT includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is FREZENT's headquarters? FREZENT is located in New York, New York, United States.Who invested in FREZENT? FREZENT has 2 investors including SOSV and  SOSV SF & NY (Fka IndieBio).When was the last funding round for FREZENT? FREZENT closed its last funding round on
obfuscation
from a Seed round.Who are FREZENT's competitors? Alternatives and possible competitors to FREZENT may include AbbVie, AstraZeneca, and  Regeneron.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ef75089 1)
|